Other factors that may increase infection risk in diabetes patients include: Immunosuppressive effects of poorly controlled hyperglycemia Neuropathy leading to reduced sensation and delayed recognition of infections Vascular complications impairing tissue perfusion and immune cell delivery Frequent antibiotic use for other infections, disrupting normal flora Obesity , which is common in type 2 diabetes and creates skin folds prone to moisture and fungal growth Conversely, medications that improve glycemic control, including GLP-1 receptor agonists and tirzepatide, generally reduce infection risk by normalizing the metabolic environment
The cost crisis GLP-1 receptor agonists represent some of the most effective treatments ever developed for obesity and type 2 diabetes
By influencing both hormonal pathways simultaneously, tirzepatide creates a synergistic effect
"Carnitine in Human Muscle Bioenergetics: Can Carnitine Supplementation Improve Physical Exercise?"
Semaglutide, a medication approved for type 2 diabetes and as a treatment for obesity, mimics an intestinal hormone that targets areas of the brain involved in appetite regulation
Download eBook References Pacific Biomarkers (2013)